Results 141 to 150 of about 3,671 (174)

Post-finasteride Syndrome: A Review of Current Literature

Current Sexual Health Reports, 2018
A constellation of persistent adverse effects—collectively termed post-finasteride syndrome (PFS)—after 5α-reductase inhibitor treatment for benign prostatic hyperplasia (BPH) and androgenic alopecia (AGA) has recently been described. The severity of these sexual, physical, neurological, and psychiatric side effects raises important concerns regarding ...
Jeffrey Than, Katherine Rodríguez, Mohit Khera   +2 more
openalex   +2 more sources

Post-finasteride syndrome - a true clinical entity?

International Journal of Impotence Research
This review critically examines Post-Finasteride Syndrome (PFS), a condition eventually reported by men who have used finasteride for androgenetic alopecia or benign prostatic enlargement and experienced persistent adverse effects after discontinuation. We explore the clinical manifestations, including sexual dysfunction, neuropsychiatric symptoms, and
Simone Cilio, Georgios Tsampoukas, Afonso Morgado, Pedro Ramos, Suks Minhas   +4 more
openalex   +3 more sources

Epigenetic Effects of Finasteride on Dopaminergic Signaling Pathways: A potential contributor to Post-Finasteride Syndrome

Physiology
Dopamine, a widely-distributed neurotransmitter in the brain and elsewhere, is important for regulating reward-motivated behavior, sexual impetus, concentration, pleasure, emotions, and genital arousal. Findings have previously implicated aberrant dopaminergic neurotransmission in mental disorders, as well as sexual and erectile dysfunction.
Churchill Ihentuge, Antonei B. Csòka
openalex   +2 more sources

Post-finasteride syndrome: newly recognised condition

Reactions Weekly, 2016

openalex   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Das Post-Finasterid-Syndrom

Gynäkologische Endokrinologie, 2017
Das Post-Finasterid-Syndrom (PFS) beschreibt eine langfristige Storung der Sexualfunktion sowie psychische und kognitive Veranderungen, die wahrend oder nach der Behandlung einer androgenetischen Alopezie (AGA) mit 1 mg Finasterid pro Tag bzw. wahrend oder nach der Therapie einer benignen Prostatahyperplasie (BPH) mit 5 mg/Tag auftreten und nach ...
Herbert Kuhl, Inka Wiegratz
openaire   +1 more source

Post-Finasteride Syndrome

2022
Mary C. Fierro, Faysal A. Yafi, Yacov Reisman   +2 more
openaire   +1 more source

Post-finasteride syndrome

BMJ, 2019
Shelly L, Gray, Todd P, Semla
openaire   +2 more sources

ERECTILE HEMODYNAMICS ASESSMENT IN ED PATIENTS WITH SELF-DIAGNOSED POST-FINASTERIDE SYNDROME (PFS)

2023
[Abstract Not Available]
Deveci, S., Sullivan, J. F., Ta, R., Mulhall, J. P.   +3 more
openaire   +1 more source

(135) Post-Finasteride Syndrome: A Case Presentation and Discussion

Journal of the Academy of Consultation-Liaison Psychiatry, 2022
Daniel Wesley, Rachel Bronsther
openaire   +1 more source

Finasteride for hair loss: a review

Journal of Dermatological Treatment, 2022
Aditya Gupta
exaly